Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Vyglipt-M 500 Tablet

Prescription Icon
Prescription Required

Marketer

Cue Labs

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vyglipt-M 500 Tablet

Metformin-Voglibose 500mg tablets combine two agents to manage elevated blood glucose in type 2 diabetes. This dual action mitigates severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. This medication may be used independently or in conjunction with other anti-diabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose readings, and other medications. Consuming this tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; cessation should only occur under physician guidance. Effective blood sugar control helps avert future complications. Continued commitment to your prescribed diet and exercise plan is crucial. Lifestyle choices are integral to diabetes management. Frequently reported side effects include nausea, diarrhea, vomiting, stomach upset, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; understanding its symptoms and management is essential. This medication is not universally suitable. Inform your physician of any prior history of kidney, liver, or cardiac disease, pancreatic issues, or significant alcohol consumption before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Interactions with other drugs are possible; disclose all medications to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Kidney function and glucose levels will be monitored regularly by your doctor throughout your treatment.

Primary Ingredients of Vyglipt-M 500 Tablet

No text provided. Please provide the text you wish to be rephrased.

Uses of Vyglipt-M 500 Tablet

Managing type 2 diabetes

Major Benefits of Vyglipt-M 500 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vyglipt-M 500 Tablet whole; do not crush, chew, or fracture it. Administer this medication with a meal.

Common Side effects of Vyglipt-M 500 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vyglipt-M 500 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vyglipt-M 500 Tablet should be administered with a meal.

How Vyglipt-M 500 Tablet works:

Metformin and linagliptin are combined in the 500mg Vyglipt-M tablet, a dual-action antidiabetic medication.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Vyglipt-M 500 Tablet is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Vyglipt-M 500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Vyglipt-M 500 Tablet while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney disease should use Vyglipt-M 500 Tablets cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Vyglipt-M 500 Tablet due to potential safety concerns. A physician's consultation is recommended.

What if you forget to take Vyglipt-M 500 Tablet :

Should you forget a dose of Vyglipt-M 500 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Vyglipt-M 500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vyglipt-M 500 Tablet

Vyglipt-M 500 Tablets rarely cause hypoglycemia by themselves; however, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate hypoglycemia. These symptoms are more pronounced if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Nausea and vomiting are possible side effects of Vyglipt-M 500 Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always consult your doctor before taking any other medication.
Vyglipt-M 500 Tablets are contraindicated in patients with allergies to its components or excipients, and should not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Vyglipt-M 500 Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in individuals under 18 years old.
Vyglipt-M 500 Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Vyglipt-M 500 Tablets and seek immediate medical attention.
Prolonged use of Vyglipt-M 500 Tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vyglipt-M 500 Tablet is safe when used as directed by your doctor. However, even with proper use, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (if also taking insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Vyglipt-M 500 Tablet
121
MRP 140
13% off